Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database

Pediatric Blood and Cancer

Volumn 60, Issue 3, 2013, Pages 508-511

  Kavcic, Marko ^a   Fisher, Brian T ^a,b   Torp, Kari ^a   Li, Yimei ^a   Huang, Yuan Shung ^b   Seif, Alix E ^a,b   Vujkovic, Marijana ^a   Aplenc, Richard ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cohort validation; Health administrative data; Pediatric acute myeloid leukemia

Indexed keywords

CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; MITOXANTRONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CHILD; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; ICD-9; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD REVIEW; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PEDIATRIC HEALTH INFORMATION SYSTEM; PEDIATRIC HOSPITAL; PEER REVIEW; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; UNITED STATES;

CHILD; COHORT STUDIES; DATABASES, FACTUAL; HEALTH INFORMATION SYSTEMS; HOSPITALS, PEDIATRIC; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LEUKEMIA, MYELOID, ACUTE; SEER PROGRAM; UNITED STATES;

EID: 84872437560     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24402     Document Type: Article

References (15)

1. Kaspers GJL, Creutzig U. Pediatric acute myeloid leukemia: International progress and future directions. Leukemia 2005; 19: 2025-2029.
2. Lange BJ, Smith FO, Feusner J, et al. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: A report from the children's oncology group. Blood 2008; 111: 1044.
3. Cooper TM, Franklin J, Gerbing RB, et al. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: A report from the Children's Oncology Group. Cancer 2012; 118: 761-7769.
4. Gibson BES, Webb DKH, Howman AJ, et al. Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial. Br J Haematol 2011; 155: 366-376.
5. Rubnitz JE, Inaba H, Dahl G, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial. Lancet Oncol 2010; 11: 543-552.
6. Sung L, Gamis A, Alonzo TA, et al. Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia. Cancer 2009; 115: 1100-1108.
7. Ethier M-C, Blanco E, Lehrnbecher T, et al. Lack of clarity in the definition of treatment-related mortality: Pediatric acute leukemia and adult acute promyelocytic leukemia as examples. Blood 2011; 118: 5080-5083.
8. Juliusson G, Lazarevic V, Hörstedt A-S, et al. Acute myeloid leukemia in the real world: Why population-based registries are needed. Blood 2012; 119: 3890-3899.
9. Benchimol EI, Manuel DG, To T, et al. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol 2011; 64: 821-829.
10. Bertoch D. Personal communication, 2011.
11. Fisher BT, Zaoutis TE, Leckerman KH, et al. Risk factors for renal failure in pediatric patients with acute myeloid leukemia: A retrospective cohort study. Pediatr Blood Cancer 2010; 55: 655-661.
12. Orsey AD, Belasco JB, Ellenberg JH, et al. Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals. Pediatr Blood Cancer 2009; 52: 761-766.
13. Fisher BT, Harris T, Torp K, et al., Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data. Med Care 2012; [Epub ahead of print] Available at: http://www.ncbi.nlm.nih.gov/pubmed/22410405. Accessed June 5, 2012.
14. Hann IM, Stevens RF, Goldstone AH, et al. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and childhood leukaemia working parties of the Medical Research Council. Blood 1997; 89: 2311-2318.
15. Creutzig U. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. Journal of Clinical Oncology 2004; 22: 4384-4393.